303 | p a g e international standard serial number (issn ...ijupbs.com/uploads/25....
TRANSCRIPT
303 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
International Journal of Universal Pharmacy and Bio Sciences 3(5): September-October 2014
INTERNATIONAL JOURNAL OF UNIVERSAL
PHARMACY AND BIO SCIENCES IMPACT FACTOR 2.093***
ICV 5.13*** Pharmaceutical Sciences REVIEW ARTICLE……!!!
NAIL DRUG DELIVERY SYSTEM: A REVIEW
GOPAL RATHORE*1
, Dr. ABHA DOSHI1
1Mumbai Education Trust‘s Institute of Pharmacy, Bandra (W), Mumbai, India.
2Gayatri herbals Pvt .Ltd, Kalika towers, Kolbad road, Thane (W), Mumbai, India.
KEYWORDS:
Nail Plate,
Bioavailability,
Antifungal, Penetrate,
Nail barrier.
For Correspondence:
GOPAL RATHORE*
Address:
Mumbai Education
Trust‘s Institute of
Pharmacy, MET
Complex, Bandra
Reclamation, Bandra
(W), Mumbai 4000-50,
India.
E-mail:
ABSTRACT
The purpose of this review is to focus the difficulties in penetration
of drug across nail plate and enhancement of bioavailability of
antifungal drug. The existing clinical system suggests that a key to
successful treatment of fungal diseases by topical application of
antifungal product in ineffectively overcoming the nail barrier.
Current topical treatments have limited therapeutic effectiveness
possibly because they cannot sufficiently penetrate in the nail plate to
transport a therapeutically sufficient quantity of antifungal drug to
the target sites to eradicate the protection. Also the analysis of the
drug's penetration is a difficult task. This review covers the anatomy
of a human nail, diseases related to nail plate, physiocochemical
properties of nail and techniques used to enhance the topical
bioavailability of the drugs across the nail, latest trends in drug
delivery across the nail.
304 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
INTRODUCTION :
Nail Anatomy & Physiology: A human nail is made up of three parts: the matrix, the plate, and
the nail bed. The matrix acts as a base for the rest of the nail, containing nerves as well as lymph
and blood vessels. The matrix creates the rest of the cells that make up the nail. The only part of the
matrix that is visible to the naked eye is the white, crescent portion of the nail known as the lunula.
On top of the matrix is the nail bed, which is made up of the dermis and epidermis. The visible
portion of the nail or the nail plate is made up of keratin and amino acids. It is formed by the
flattened, dead cells pushed up by the matrix and the bone of the finger determines its shape. Nails
are meant to protect the fingertips and toes as well as the tissues around them from injury. It also
helps the fingers themselves function in a more accurate manner. The nails place slightly more
weight on the finger tips allowing for more precise movements. It also increase sensitivity in the
fingertip. Despite the fact that the exposed part of the nail is comprised of dead cells it is attached to
a very sensitive portion of skin full of nerves. Any contact with the nail sends signals directly to
these nerves increasing sensitivity [8]
.
Fig. 1: Structure of human finger nail
COMMON DISEASES OF NAIL:
The nail plate may appear abnormal as result of acongenital defect, disease of skin with
involvement of the nail bed, systematic disease, reduction of blood supply, local trauma, tumors of
the nail fold or nail bed, infection of the nail fold and infection of the nail plate.
Leuconychia:
Leuconychia is the white spots or one or more lines appears on nails & grow out spontaneously.
The disorder may be caused by trauma, illness, malnutrition or any major metabolic condition,
chemotherapy or other damaging event and is the result of any interruption in the protein formation
of the nail plate.
Treatment: - To relief from the symptoms by including lot of nutrition in your daily diet. Proteins,
vitamins and zinc are essential elements that are to be added in daily food.
305 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
Fig. 2. Leuconychia
Onychomycosis:
Onychomycosis is yellow-brown patches near the lateral border of the nail. Beneath the masses of
soft horny debris accumulate and the nail plate gradually becomes thickened, broken and
irregularly distorted. One or many nails may be affected and there may be associated infection of
the skin. Most of the infections are caused by Trichophyton rubrum, T. inerdigitale, TineaUnguis,
or ringworm of the nails, is characterized by nail thickening, deformity and eventually results in
nail plate loss [4,5]
.
Fig 3. Onychomycosis
Treatment: orally antifungal terbinafine, itraconazole.
Topically application amorolfine, ciclopirox.
Onychatrop:
Onychatrop is an atrophy or wasting away of the nail plate which causes it to lose its luster,
become smaller and sometimes shed entirely. Injury or disease may account for this irregularity.
Treatment: orally use drug triamcinolone.
Fig.4. Onychatrop
Onychogryposis:
Onychogryposis are claw-type nails are characterized by a thickened nail plate and are often the
result of trauma. This type of nail plate will curve inward, pinching the nail bed and sometimes
requires surgical intervention to relieve the pain.
Treatment: use topical antifungal drug.
Marketed formulation: funginix, dermisil, terrasil, zetaclear.
Fig.5. Onychogryposis
306 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
Onychorrhexis:
Onychorrhexis are brittle nails which often split vertically, peel and \ or have vertical ridges. This
irregularity can be the result of heredity, the use of strong solvents in the workplace, including
household cleaning solutions. Although oil or paraffin treatments will rehydrate the nail plate, one
may wish to confer with a physician to rule out disease.
Treatment: Cream or lotion consisting of natural plant oil will keep the hand moist and help cure
the disease.
Fig.6. Onychorrhexis
Onychauxis:
Onychauxis is evidenced by over thickening of the nail plate and may be the result of internal
disorders.
Treatment: use of marijuana cream.
Prevention by: proper nail trimming and wear light shoes.
Fig.7. Onychauxis
Yellow Nail Syndrom:
Yellow Nail Syndrome (YNS) is a rare condition characterized by yellow nails with lack cuticle,
grows slowly and is loose or detached associated with onycholysis in one or more nails.
Treatment: topical – zinc application, clarithromycin.
Oral – tocopherol.
Fig.8.Yellow Nail Syndrom
Koilonychia:
Koilonychia is usually caused through iron deficiency anemia. These nails show raised ridges
and are thin and concave.
Treatment: iron supplements.
Fig.9. Koilonychia
307 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
Melanonychia:
Melanonychia are vertical pigmented bands, often described as nail ‗moles‘, which usually form
in the nail matrix. It could signify a malignant melanoma or lesion. Dark streaks maybe a normal
occurrence in dark-skinned individuals and are fairly common.
Treatment: cure by use of natural – hoodia gordonii plus. Revitol cellulite solutions.
Fig.10. Melanonychia
Psoriasis:
The nails are characterized by raw, scaly skin and are sometimes confused with eczema. When it
attacks the nail plate, it will leave it pitted, dry and it will often crumble. The plate may separate
from the nail bed and may also appear red, orange or brown, with red spots in the lunula. Do not
attempt salon treatments on clients with nail psoriasis.
Treatment: injection of corticosteroids, 5-fluorouracil.
Fig.11. Psoriasis
Paronychia:
Paronychia is a inflammation involving the lateral and posterior fingernail folds. Paronychia
infection of the nail fold can be caused by bacteria, fungi and some viruses. This type of infection
is characterized by pain, redness and swelling of the nail folds.
Treatment: Orally amoxicillin with clavulanic acid. Topically ketoconazole cream and
Hydrocortisone.
Fig.12. Paronychia
REQUIREMENTS FOR LOCAL THERAPY
• Potential active (antifungal) agent.
• High concentration of the drug in the formulation.
• Diffusion at levels exceeding MIC.
• Adequate method of delivery.
• Ease and convenience of application.
308 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
The diffusion of drug through nail depends on:
1. The Physicochemical properties of the nail
2. The Properties of chemical
3. The Physicochemical characteristics of the vehicle containing the active agent.
1. PHYSICOCHEMICAL PROPERTIES OF NAIL
The entire nail structure is hard keratin. The hardness of the nail plate not only depends on the
junctions between the cells and the transverse orientation of the keratin filaments with respect to
the axis of the nail growth. Moreover, the multiplicity of the lateral bonds between keratin fibers
(disulfide bridges, hydrogenbonds, acid- base bonds, electrostaticbonds) also account for high
resistance. The keratin of nails has been classified as ―hardtrichocyte keratins‖. It contains
significant amount of phospholipids, mainly in the dorsal and intermediate layers, which contribute
to its flexibility [2]
.
2. PROPERTIES OF THE CHEMICAL:
Among the other physicochemical properties of chemicals, these are the important set of
properties which affect the most, the drug absorption through nail.
a) SOLUTE MOLECULAR SIZE:
As the nail plate is produced mainly by differentiation of cells in the nail matrix and it comprises
three horizontal layers: a thin dorsal lamina the thicker intermediate lamina and a ventral layer
from the nail bed. Because the nail plate is composed of many strands of keratin held together
through disulfide bonds, the space between the strands must have a finite size causing the nail
plate to act like a molecular sieve. Small molecules can weave through these spaces while larger
molecules are unable to pass. The molecular weight of most antifungal agents is >300 Da.
accordingly, these drugs will have difficulty penetrating the nail plate, a likely reason for low
clinical efficacy observed. So, the optimum small particle size of the drug is the fore most
prerequisite for formulation point of view.
b) HYDROPHILICITY / HYDROPHOBICITY
There is a marked difference between the permeability characteristics of the nail plate and the
epidermis. These observed differences have been largely attributed to the relative amounts of lipid
and protein regulation within the structures and the possible differences in the physicochemical
nature of the respective phases. The lipid levels in the nail plate are nearly 1%, which combined
with lower water levels of about only 10% affords the nail plate. Studies using DMSO,
homologous alcohols of different molecular weights have shown that, the nail plate was
permeable to dilute aqueous solutions of low molecular weight homologous alcohols. As well as
309 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
the significant decrease in the permeation of the hydrophobic entity n-octanol following
delipidization of nail plate by chloroform / methanol also suggested that the nail plate possessed a
highly ―polar‖ penetration route and become rate controlling for hydrophobic solutes. The
chemical composition of nail and experimental evidence indicate that the aqueous pathway plays
a dominant role in drug penetration into nail. Water is the principal plasticizer for the nail. Upon
being hydrated, hard nail plates become softer and more flexible. Nail hydration is influenced by
many factors, such as solution pH and certain chemicals [12]
.
3. PROPERTIES OF VEHICLE:
pH of vehicle and solute charge
Antifungal agents have a range of pKa values and so studies have been reported that compare the
penetration of the ionic and non-ionic forms of the parent. These studies investigated the
penetration of miconazole (pKa=6.7), benzoic acid (pKa= 4.2), pyridine (pKa=5.3) and 5-
fluorouracil (pKa=7.9) in vehicles over pH range from 2 to 8.5. In the case of miconazole, it was
reported that penetration was in dependent of the pH of the vehicle. However, in all the other
cases, the ionic forms of the parent did not penetrate as well, as the non-ionic forms. A recent
study investigating the penetration of ionic and non-ionic compounds and the relationship with
molecular weight also found non-ionic compounds penetrate better[11]
.
ENHANCEMENT OF NAIL PERMEATION
Targeting drug treatment to diseases that reside within or below the nail plate is problematic due
to the highly restrictive barrier of the human nail. To optimize topical formulations for nail drug
delivery, inclusion of an effective penetration enhancer (PE) is imperative. Research is currently
being undertaken to design novel in vitro methods to assess the ability of compounds to penetrate
the nail plate. In addition, methods of chemical and physical analysis of the nail are being
developed.
(A) PHYSICAL MEANS
The composition of the nail plate suggests that, the use agents that effect by delipidization or
fluidization of the intracellular lipids can help in drug permeation. Many approaches have been
used to resolve these barriers to drug delivery [2]
.
These include:
a. Transdermal diffusion
b. Iontophoresis
c. Electroporation
d. Microneedles & thermal poration Iontophoresis
310 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
Electroporation: is a method in which, with the application of an electric pulse of about 100–
1,000 V/cm creates transient aqueous pores in the lipid bilayers making the solute particles
permeable through it [11]
.
Microneedle enhanced delivery systems: a method using arrays of microscopic needles to open
pores in the SC directly to the skin capillaries; also has the advantage of being too short to
stimulate the pain fibers, thus facilitating drug permeation.
Other physical techniques include manual and electrical nail abrasion, acid etching, ablation by
lasers, microporation, application of low-frequency ultrasound and electric currents.
(B) CHEMICAL MEANS
The high disulfide bond content of nail has been found to be responsible for the hardness of the
nail. In recent years, the ability of compounds that possess –SH groups to increase nail
permeation has been documented. Promising enhancers in sulfhydryl containing endopepetidase
enzyme, 2-mercaptoethanol, 1,4-Dithiothreitol which contains 2-SH groups and various
reducing sulfites and bisulfites. These increase the ability of the nail to hydrate. As well as nail
softening agents (keratolytic agents) like urea and salicylic acid can be used in the formulation
for enhancing the drug permeation through chemical-mean [2]
.
Approaches of nail drug delivery
a) Topical application
Oral administration of antifungal therapy is inherently associated with GI and systemic side
effects. Obviously, topical delivery is the most desired therapy due to relatively less severe side
effects and better patient compliance particularly in case of pediatric patients. Unfortunately,
there are at least two factors that could limit the accumulation and activity of drugs in the nail on
topical application. First, the physicochemical properties of the drug need to be favorable for
absorption through nail matrix. The nail matrix reported to be relatively more permeable to polar
compounds than nonpolar compounds. Second, binding of the drug to keratin reduces the
availability of the free drug. Antifungal drugs are reported to possess high binding affinity to
keratin.
b) Chemical penetration enhancement
The common approach for enhancing nail drug delivery has been to use keratolytic and
thiolytic agents. These agents are known to increase the permeability of nail matrix by chemical
modification of keratin. However, their permeability enhancement potential is limited by the
factors like penetrability of enhancer and the duration of its presence in the nail matrix might
311 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
significantly influence the chemical modification of keratin. Topical monotherapy is considered
less efficient in treating nail disorders such as onychomycosis due to poor trans‐nail
bioavailability of drugs.
c) Physical penetration enhancement
James and coworkers carried out iontophoresis of prednisolone sodium phosphate across
thumb nail and determined the time course of prednisolone in plasma However, there is need for
systematic preliminary studies to assess the efficacy and resolve the mechanistic aspects of
iontophoresis across nail (James M. P.,et al., 1986). Recently the iontophoretic trans‐nail
delivery method showed good results in treating nail fungal syndromes. S.Narsimha Murthy and
co‐workers have studied the effect of Iontophoresis on the permeability of salicylic acid across
human nail plate. They conducted diffusion study using Franz diffusion cell incorporated with
electrode with it (Murthy S.N., et al., 2005). The results showed drastic increase in the
permeability of a test penetrant across nail plate as compared with the conventional method of
penetration [11]
.
Recent advances in nail delivery
Apart from the traditional formulation like nail lacquers, nail varnish, and nail patches recent
technologies are introduced in the development of more efficient drug delivery. Here some of the
recent technologies are listed which open the new horizons for drug delivery to the human
nail[12]
.
a) Electrochemotherapy for Nail disorders :
The goal of this therapy is to develop an active method of drug delivery across the nail plate
which in turn is believed to increase the success rate of topical monotherapy and decrease the
duration of treatment of nail disorders. Currently, the electrically mediated techniques for drug
delivery across the nail plate are investigated. Recently the iontophoretic trans‐nail delivery
method studied. Iontophoresis was found to enhance the transport of drugs across the nail plate
significantly. Similar to transdermal iontophoresis, the predominant mechanisms contributing to
enhanced transport of drugs in the case of transnail iontophoresis are electrophoresis
electroosmosis. Iontophoretic permselectivity of the human nail plate and its applicability on
the trans‐nail delivery of drugs are also under investigation.
b) Mesoscissioning technology:
Mesoscissioning technology creates a micro‐conduit through the skin or nail within a specified
depth range. Fully open pathways can be painlessly scized (cut) through the stratum corneum of
the skin or through the nail. Microconduits, 300‐500 microns in diameter, are produced within
312 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
seconds and without sensation. These pathways can be used to deliver drugs across the skin
(proof‐of‐concept in vivo human experiments have shown full anaesthesia occurs within 3
minutes through microconduits compared with 1+hour through intact stratumcorneum). Such
microconduits also permit access for subdermal analyte. extraction (including blood for
glucosetesting). In addition, they reduce the skin electrical impedance to less than 1000 ohms
for biopotential measurements. In nails, microconduits quickly reduce the painful pressure of
subungual hematoma (black toe) and could serve as a prophylactic to prevent such pressure
build‐up in runner's nails.
c) NanoPatch Nail Fungus:
NanoPatch Fungus uses AC/DC electrochemistry and targeted drug delivery to actively push
antifungal drugs right through the nail cuticle to the actual location of the fungus growth. This
would be the first treatment option to directly target nail fungus at its source of growth[10]
.
Table 1: Marketed formulations for nail disorders
Sr.No.
Name of product
Name of drug
Uses/Indications
Name of
company
1 Eco‐Nail
nail lacquer
5%
econazole+18%
SEPA
nail lacquer
Promotes the release of
econazole from dried lacquer
film, creating a large chemical
gradient at the lacquernail
interface, to drive econazole in
the deep nail plate SEPA acts as
a percutaneous penetration
enhancer which itself has no
effect on nail and do not
penetrate nail.
MacroChem
Corporation
2 Loceryl
nail film
antifungal
drug,
amorolfine
A non‐water‐soluble film of
amorolfine formed on the nail
plate, and this film remains in
place for 1 week. The film
contains a high concentration of
amorolfine and forms a depot
from which the drug is
delivered and which allows the
drug to permeate the nail plate.
Galderma
Australia Pty
Ltd
3 Umecta nail
film
Urea 40%
Psoriatic nails, brittle and thick
nails, and calluses
JSJ
Pharmaceuticals
4 Tazorac 0.1%
Gel
Tazarotene
Used in the Treatment of
Fingernail
Psoriasis
Allergan Inc
313 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
5 Zalain nail patch
Sertaconazol
nitrate
Once‐a‐week nail patch for
treatment of onychomycosis &
onychodystrophy
Labtec
6 Penlac nail
lacquer
Ciclopirox topical
solution
a broad‐spectrum antifungal
medication that also has
antibacterial and
antiinflammatory
properties
Dermik
Laboratories
Inc.
CONCLUSION:
Drug delivery to the nail (ungula drug delivery) constitutes a major challenge, with the lack of
understanding of both the barrier properties of the nail and formulations to achieve enhanced ungula
delivery restricting the efficiency of topical treatment for nail disorders. Nail diseases like
onycomycisis, nail psoriasis, yellow nail syndrome, paronychia and many more, being cured
successfully using medicated lacquers. This avoids the oral toxicity of antifungal drug and provides
longer contact time at the site of action. This systemic review covers the anatomy of a human nail,
diseases related to nail plate, the formulation designed for nail application and some techniques
used to enhance the topical bioavailability of the drug across the nail, latest trends in drug delivery
across the nail.
REFERENCES:
1. Akomeah F., Nazir T., Martin G., BrownM. Effect of heat on the percutaneous absorption
and skin retention of three model penetrants. Eur. J. Pharm. 2004; 21: 337‐345.
2. Baden H. P., Goldsmith L. A., Fleming G.A comparative study of the physicochemical
properties of human keratinized tissues. Biochim Biophys Acta. 1973; 322: 269–278.
3. Bodhibukkana C., Srichana T.,Kaewnopparat S., Tangthong N.,Bouking P., Martin G.P.,
Suedee R.Composite membrane of bacterially derived cellulose and molecularly imprinted
polymer for use as atransdermal Enantioselective controlled‐release system of
racemicpropranolol. J. Control. Rel., 2006; 113:43‐56.
4. Bran R, Kaokhov A. Topical antifungal drugs for the treatment of onychomycosis: An
overview of current strategies for monotherapy and combination therapy. J Euro Acad
Dermat Venorol. 2005; 19 :21–29.
5. Chaudhari P. D., Chaudhari S. P., KolsureP. K., Bothiraja C. Drug Delivery Through Nail ‐
A Review. Pharmainfo.net. 2006;4(1).
6. Lawry M, Dermatologic Therapy Vol. 20, 2007, 60–67.
7. Debruyne D., Coquerel A. Pharmacokinetics of antifungal agents in onychomycosis. Clin
Pharmacokinet. 2001; 40: 441–472.
314 | P a g e International Standard Serial Number (ISSN): 2319-8141
Full Text Available On www.ijupbs.com
8. Dykyj J. D. Anatomy of the nail clin padiatr.med. surgery. 1989; 6(2): 521‐28.
9. Forslind,B. On the structure of the normal nail. A scanning electrion microscopy study.
Archives fodermatologishe for schung. 1975; 251:199.
10. James M. P., Graham R. M. English J.Percutaneous iontophoresis prednisolone—A
pharmacokinetic study. Clinical and experimental studyII. 1986; 54–61.
11. Kenneth A., Gordon L., John R. Physiochemical characterization of the human nail. J.
keratinized tissues. Biochim Biophys Acta. 1973; 322: 269–278.
12. Murthy S.N., Zhao Y., Hui S.W., Sen A.Electroporation and transcutaneou extraction(ETE)
for pharmacokinetic studies of drugs. J Control Release. 2005; 105: 132–141.
13. NanoPatchAC, Inc, www.nanopatchac.co. Accessed May 29, 2009.Path Scientific, LLC,
111 www.pathscientific.com.Accessed May 29, 2009.
14. The University of Mississippi,www.pharmacy.olemiss.edu. Accessed May 28, 2009.
15. Walters K. A., Flynn G. L. Penetration of the human nail plate: The effects of vehicle pH
on the permeation of miconazole. J Pharm Pharmacol. 1985;37: 498-499.
16. R.P. Patel, S.A. Naik, N.A. Patel, A.M. Suthar, Drug delivery across human nail;
International journal of current pharmaceutical research vol.1.2009, 1-7.